CTLP Cantaloupe posts 50 percent Q1 2026 EPS miss shares edge higher despite underwhelming quarterly earnings WidePoint Corporation WYY Stock Why Free Cash Flow Sinks 20260420 10x Genomics TXG Stock Sentiment Shift Nudges Down 20260420 FrontView REIT FVR Stock Fair Value Analysis 058 20260420 ISPC iSpecimen shares drop 196 after massive Q3 2024 EPS miss far trails analyst expectations Valero Energy Corp VLO Strategic Refinery Network Positioning Drives Bullish Upgrade Outlook DOCU DocuSign delivers strong Q1 2026 results shares climb 431 on 82 year over year revenue growth Edison International EIX Probability of Extended Earnings Beat Streak Ahead of Q1 2026 Release Marathon Petroleum Corp MPC BAH Booz Allen delivers strong Q1 2026 EPS beat and 124 YoY revenue growth but shares fall 448 PSMT PriceSmart posts Q1 2026 earnings beat 72 percent year over year revenue growth lifts shares modestly FOSL Fossil Group posts massive Q4 2025 EPS miss 123 revenue decline shares slip 221 AACG ATA Creative delivers flat Q3 2024 year over year revenue negative earnings and steady share price Cohen PTA Stock Analysis Today Breakout Watch 20260420 What is driving movement in Ingersoll Rand IR stock 016 20260420 HighPeak Energy HPK Stock Sentiment Signals Institutional Selling 20260427 iShares Core SP SmallCap ETF IJR Comparative Analysis Against Peer VB for LongTerm SmallCap Portfolio Allocation SUIG Sui Group reports far wider than expected Q4 2025 loss even as shares edge modestly higher today Lakeside LSH Stock vs Competition Selloff Intensifies 20260420 Pfizer Inc PFE Padcev Combination Therapy Receives FDA Priority Review for Expanded Bladder Cancer Indication WFRD Weatherford Q1 2026 EPS beats estimates by 391 percent shares jump 545 percent on positive investor sentiment What is the outlook for Phunware PHUN stock this quarter Q4 2025 Earnings Beat Estimates Wheels Up UP Stock Style Rotation Volatility Increases 20260420 Regeneron Pharmaceuticals REGN TD Cowen Ups Price Target Ahead of Fiscal Q1 Results Supported by FDA Gene Therapy Approval Is TFI TFII stock overvalued by the market TFI posts 263 EPS beat topping street estimates